Filing Flows › Amgen (AMGN) › Capital expenditures
Amgen (AMGN) capital expenditures by quarter
Amgen's capital expenditures were $587M in Q3 2026 (third quarter 2026), +17% from Q2 2026. Over the last 7 quarters it ranged from $369M (Q2 2025) to $700M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $587M | +17% | +35% |
| Q2 2026 | $500M | -29% | +36% |
| Q1 2026 | $700M | +17% | +75% |
| Q4 2025 | $600M | +38% | — |
| Q3 2025 | $436M | +18% | — |
| Q2 2025 | $369M | -8% | — |
| Q1 2025 | $400M | — | — |
Q3 2026 at a glance
Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Amgen's capital expenditures?
Amgen's capital expenditures were $587M in Q3 2026 (third quarter 2026), +17% from Q2 2026.
How has Amgen's capital expenditures changed?
Over the last 7 quarters it ranged from $369M (Q2 2025) to $700M (Q1 2026).